High-fat-diet-induced weight gain ameliorates bone loss without exacerbating AβPP processing and cognition in female APP/PS1 mice

Frontiers in Cellular Neuroscience

Volumn 8, Issue AUG, 2014, Pages

  Peng, Yunhua ^a   Liu, Jing ^a   Tang, Ying ^a   Liu, Jianshu ^b   Han, Tingting ^b   Han, Shujun ^a   Li, Hua ^a   Hou, Chen ^a   Liu, Jiankang ^a   Long, Jiangang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Shaanxi Translational Center for Functional Foods   (China)

Author keywords

Alzheimer's disease; Bone mineral density; Leptin; Osteoporosis; Weight gain

Indexed keywords

EID: 84905693592     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00225     Document Type: Article

References (71)

1. Akhter, M., Wells, D., Short, S., Cullen, D., Johnson, M., Haynatzki, G., et al. Bone biomechanical properties in LRP5 mutant mice. Bone 35,162-169. doi:10.1016/j.bone.2004.02.018
2. Albala, C., Yanez, M., Devoto, E., Sostin, C., Zeballos, L., and Santos, J. (1996). Obesity as a protective factor for postmenopausal osteoporosis. Int. J. Obes. Relat. Metab. Disord. 20, 1027-1032.
3. Alzheimer's Association. (2014). 2014 Alzheimer's disease facts and figures. lzheimersDement. 10,e47-e92. doi:10.1016/j.jalz.2014.02.001
4. Andersen, K., Launer, L. J., Dewey, M. E., Letenneur, L., Ott, A., Copeland, J. R., et al. (1999). Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53, 1992-1997. doi:10.1212/WNL.53.9.1992
5. Andersen, S., Frederiksen, K. D., Hansen, S., Brixen, K., Gram, J., and St0ving, R. K. (2014). Bone structure and estimated bone strength in obese patients evaluated by high-resolution peripheral quantitative computed tomography. Calcif. Tissue Int. 95,19-28. doi:10.1007/s00223-014-9857-4
6. Barron, A. M., Rosario, E. R., Elteriefi, R., and Pike, C. J. (2013). Sex-specific effects ofhigh fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease. PLoS ONE 8:e78554. doi:10.1371/journal.pone.0078554
7. Bonda, D. J., Stone, J. G., Torres, S. L., Siedlak, S. L., Perry, G., Kryscio, R., et al. (2013). Dysregulation ofleptin signaling inAlzheimer disease: evidence for neuronal leptin resistance. J. Neurochem. 128, 162-172. doi:10.1111/jnc.12380
8. Bonnet, N., Bernard, P., Beaupied, H., Bizot, J., Trovero, F., Courteix, D., et al. (2007). Various effects of antidepressant drugs on bone microarchitecture, mechanical properties and bone remodeling. Toxicol. Appl. Pharmacol. 221, 111-118. doi:10.1016/j.taap.2007.02.005
9. Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., et al. (1997). Accelerated amyloid deposition in the brains of transgenic mice oexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945. doi:10.1016/S0896-6273(00)80974-5
10. Bouxsein, M. L., Boyd, S. K., Christiansen, B. A., Guldberg, R. E., Jepsen, K. J., and Müller, R. (2010). Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25, 1468-1486. doi:10.1002/jbmr.141
11. Bredesen, D. E., and John, V. (2013). Next generation therapeutics for Alzheimer's disease. EMBOMol. Med. 5,795-798. doi:10.1002/emmm.201202307
12. Burguera, B., Hofbauer, L. C., Thomas, T., Gori, F., Evans, G. L., Khosla, S., etal. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142, 3546-3553. doi:10.1210/endo.142.8.8346
13. Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292-295. doi:10.1056/NEJM199602013340503
14. Couzin-Frankel, J. (2014). Diet studies challenge thinking on proteins versus carbs. cience 343, 1068. doi:10.1126/science.343.6175.1068
15. Cronin-Stubbs, D., Beckett, L. A., Scherr, P. A., Field, T. S., Chown, M. J., Pilgrim, D. M., et al. (1997). Weight loss in people with Alzheimer's disease: a prospective population based analysis. Br. Med. J. 314, 171-174. doi:10.1136/ bmj.314.7075.178
16. De Laet, C., Kanis, J., Oden, A., Johanson, H., Johnell, O., Delmas, P., et al. (2005). Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos. Int. 16,1330-1338. doi:10.1007/s00198-005-1863-y
17. Deacon, R. M., and Rawlins, J. N. P. (2005). Hippocampal lesions, species-typical behaviours and anxiety in mice. Behav. Brain Res. 156, 241-249. doi:10.1016/j. bbr.2004.05.027
18. El Khoury, N., Gratuze, M., Papon, M.-A., Bretteville, A., and Planel, E. (2014). Insulin dysfunction and Tau pathology. Front. Cell. Neurosci. 8:22. doi:10.3389/ fncel.2014.00022
19. Farooki, A. (2009). Central obesity and increased risk of dementia more than three decades later. Neurology 72, 1030-1031. doi:10.1212/01.wnl.0000343499. 72241.ea
20. Felson, D. T., Zhang, Y., Hannan, M. T., and Anderson, J. J. (1993). Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J. Bone Miner. Res. 8, 567-573. doi:10.1002/jbmr. 5650080507
21. Flegal, K. M., Kit, B. K., Orpana, H., and Graubard, B. I. (2013). Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309, 71-82. doi:10.1001/jama.2012.113905
22. Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., and Flier, J. S. (1995). Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1, 1311-1314. doi:10.1038/ nm1295-1311
23. Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., et al. (2006). Characterization of amyloid deposition in the APP- swe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 24, 516-524. doi:10.1016/j.nbd.2006.08.017
24. Gerlai,R. (1998). A new continuous alternation task in T-maze detects hippocampal dysfunction in mice: a strain comparison and lesion study. Behav. Brain Res. 95, 91-101. doi:10.1016/S0166-4328(97)00214-3
25. Greco, E. A., Francomano, D., Fornari, R., Marocco, C., Lubrano, C., Papa, V., et al. Negative association between trunk fat, insulin resistance and skeleton in obese women. WorldJ. Diabetes 4, 31-39. doi:10.4239/wjd.v4.i2.31
26. Ho, L., Qin, W., Pompl, P. N., Xiang, Z., Wang, J., Zhao, Z., et al. (2004). Diet- induced insulin resistance promotes amyloidosis in a transgenic mouse model ofAlzheimer's disease. FASEB J. 18, 902-904. doi:10.1096/fj.03-0978fje
27. Holloway, W. R., Collier, F. M., Aitken, C. J., Myers, D. E., Hodge, J. M., Malakellis, M., et al. (2002). Leptin inhibits osteoclast generation. J. Bone Miner. Res. 17, 200-209. doi:10.1359/jbmr.2002.17.2.200
28. Ionova-Martin, S., Wade, J., Tang, S., Shahnazari, M., Ager, III. J., Lane, N., et al. Changes in cortical bone response to high-fat diet from adolescence to adulthood in mice. Osteoporos. Int. 22, 2283-2293. doi:10.1007/s00198-010- 1432-x
29. Jamsa, T., Jalovaara, P., Peng, Z., Vaananen, H. K., and Tuukkanen, J. (1998). Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone 23,155-161. doi:10.1016/S8756-3282(98)00076-3
30. Johansson, H., Kanis, J. A., Oden, A., McCloskey, E., Chapurlat, R. D., Christiansen, C., et al. (2014). A Meta-analysis of the association of fracture risk and body mass indexinwomen. J. BoneMiner. Res. 29,223-233. doi:10.1002/jbmr.2017
31. Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., et al. (2000). Metabolic cardiovascular syndrome and risk of dementia in Japanese- American elderly men. The Honolulu-Asia Aging Study. Arterioscler. Thromb. Vase. Biol. 20, 2255-2260. doi:10.1161/01.ATV.20.10.2255
32. Khosla, S., Atkinson, E. J., Riggs, B. L., and Melton, L. J. (1996).Relationship between body composition and bone mass in women. J. Bone Miner. Res. 11, 857-863. doi:10.1002/jbmr.5650110618
33. Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kareholt, I., Winblad, B., et al. (2005). Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 62, 1556-1560. doi:10.1001/archneur. 62.10.1556
34. Leboucher, A., Laurent, C., Fernandez-Gomez, F. J., Burnouf, S., Troquier, L., Eddark- aoui, S., et al. (2013). Detrimental effects of diet-induced obesity on tau pathology are independent of insulin resistance in tau transgenic mice. Diabetes 62, 1681-1688. doi:10.2337/db12-0866
35. Lee, D.-Y., Na, D. L., Seo, S. W., Chin, J., Lim, S.-J., Choi, D., et al. (2012). Association between cognitive impairment and bone mineral density in postmenopausal women. Menopause 19, 636-641. doi:10.1097/gme.0b013e31823dbec7
36. Lelovas, P. P., Xanthos, T. T., Thoma, S. E., Lyritis, G. P., and Dontas, I. A. (2008). The laboratory rat as an animal model for osteoporosis research. Comp. Med. 58, 424.
37. Lieb, W., Beiser, A. S., Vasan, R. S., Tan, Z. S., Au, R., Harris, T. B., et al. (2009). Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302, 2565-2572. doi:10.1001/jama.2009.1836
38. Lin, S., Thomas, T., Storlien, L., and Huang, X. (2000). Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int. J. Obes. Relat. Metab. Disord. 24, 639-646. doi:10.1038/sj.ijo.0801209
39. Loskutova, N., Honea, R. A., Vidoni, E. D., Brooks, W. M., and Burns, J. M. (2009). Bone density and brain atrophy in early Alzheimer's disease. J. Alzheimers Dis. 777-785. doi:10.3233/JAD-2009-1185
40. Martin, T. J., and Sims, N. A. (2005). Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11, 76-81. doi:10.1016/j. molmed.2004.12.004
41. McNeilly, A. D., Williamson, R., Balfour, D. J., Stewart, C. A., and Sutherland, C. A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. Diabetologia 55, 3061-3070. doi:10.1007/s00125-012-2686-y
42. McNeilly, A. D., Williamson, R., Sutherland, C., Balfour, D. J., and Stewart, C. A. (2011). High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behav. Brain Res. 217, 134-141. doi:10.1016/j.bbr.2010.10.017
43. Mielke, J. G., Nicolitch, K., Avellaneda, V., Earlam, K., Ahuja, T., Mealing, G., et al. (2006). Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice. Behav. Brain Res. 175, 374-382. doi:10.1016/j.bbr.2006.09.010
44. Moroz, N., Tong, M., Longato, L., Xu, H., and De La Monte, S. M. (2008). Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J. Alzheimers Dis. 15, 29-44. doi:10.1096/fj.03-0978fje
45. Ravn, P., Cizza, G., Bjarnason, N., Thompson, D., Daley, M., Wasnich, R., et al. (1999). Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J. Bone Miner. Res. 14, 1622-1627. doi:10.1359/jbmr.1999.14.9.1622
46. Reid, I. R. (2002). Relationships among body mass, its components, andbone. Bone 31, 547-555. doi:10.1016/S8756-3282(02)00864-5
47. Reid, I. R., Plank, L. D., and Evans, M. C. (1992). Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J. Clin. Endocrinol. Metab. 75, 779-782. doi:10.1210/jc.75.3.779
48. Reisel, D., Bannerman, D., Schmitt, W., Deacon, R., Flint, J., Borchardt, T., et al. Spatial memory dissociations in mice lacking GluR1. Nat. Neurosci. 5, 868-873. doi:10.1038/nn910
49. Sato, Y., Asoh, T., and Oizumi, K. (1998). High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 23, 555-557. doi:10.1016/S8756-3282(98)00134-3
50. Shen, C.-L., Chyu, M.-C., Cao, J. J., and Yeh, J. K. (2013). Green tea polyphenols improve bone microarchitecture in high-fat-diet-induced obese female rats through suppressing bone formation and erosion. J. Med. Food 16, 421-427. doi:10.1089/jmf.2012.0199
51. Sheu, Y., and Cauley, J. A. (2011). The role of bone marrow and visceral fat on bone metabolism. Curr. Osteoporos. Rep. 9, 67-75. doi:10.1007/s11914-011- 0051-6
52. Sienkiewicz, E., Magkos, F., Aronis, K. N., Brinkoetter, M., Chamberland, J. P., Chou, S., et al. (2011). Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metab. Clin. Exp. 60,1211-1221. doi:10.1016/j.metabol.2011.05.016
53. Solon-Biet, S. M., McMahon, A. C., Ballard, J. W. O., Ruohonen, K., Wu, L. E., Cogger, V. C., et al. (2014). The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 418-430. doi:10.1016/j.cmet.2014.02.009
54. Stewart, R., Masaki, K., Xue, Q.-L., Peila, R., Petrovitch, H., White, L. R., et al. (2005). A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch. Neurol. 62, 55-60. doi:10.1001/archneur. 62.1.55
55. Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., et al. (2012). Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316-1338. doi:10.1172/JCI59903
56. Tan, Z. S., Seshadri, S., Beiser, A., Zhang, Y., Felson, D., Hannan, M. T., et al. Bone mineral density and the risk of Alzheimer disease. Arch. Neurol. 62, 107-111. doi:10.1001/archneur.62.1.107
57. Thomas, T., Gori, F., Khosla, S., Jensen, M. D., Burguera, B., and Riggs, B. L. (1999). Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140, 1630-1638. doi:10.1210/en.140.4.1630
58. Tremollieres, F., Pouilles, J., and Ribot, C. (1993). Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. J. Clin. Endocrinol. Metab. 77, 683-686. doi:10.1210/jcem. 77.3.8370689
59. Turner, C. (2002). Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos. Int. 13, 97-104. doi:10.1007/s001980200000
60. Vorhees, C. V., and Williams, M. T. (2006). Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1, 848-858. doi:10.1038/nprot.2006.116
61. Wada, T., Nakashima, T., Hiroshi, N., and Penninger, J. M. (2006). RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17-25. doi:10.1016/j.molmed.2005.11.007
62. Weller, I., and Schatzker, J. (2004). Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann. Epidemiol. 14, 319-324. doi:10.1016/j. annepidem.2003.08.005
63. White, H., Pieper, C., and Schmader, K. (1998). The association ofweight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J. Am. Geriatr. Soc. 46, 1223-1227.
64. White, H., Pieper, C., Schmader, K., and Fillenbaum, G. (1996). Weight change in Alzheimer's disease. J. Am. Geriatr. Soc. 44, 265-272.
65. Xia, W.-F., Jung, J.-U., Shun, C., Xiong, S., Xiong, L., Shi, X.-M., et al. (2013). Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by n-acetyl-l-cysteine. J. BoneMiner. Res. 28,2122-2135. doi:10.1002/jbmr.1954
66. Xue, Y., Jiang, L., Cheng, Q., Chen, H., Yu, Y., Lin, Y., et al. (2012). Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. PLoS ONE 7:e46740. doi:10.1371/journal.pone. 0046740
67. Yang, M.-W., Wang, T.-H., Yan, P.-P., Chu, L.-W., Yu, J., Gao, Z.-D., et al. (2011). Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine 18, 205-213. doi:10.1016/j.phymed. 2010.05.011
68. Yang, P., Jia, B., Ding, C., Wang, Z., Qian, A., and Shang, P. (2009). Whole-body vibration effects on bone before and after hind-limb unloading in rats. Aviat. Space Environ. Med. 80, 88-93. doi:10.3357/ASEM.2368.2009
69. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl.Acad. Sci. U.S.A. 95,3597-3602. doi:10.1073/pnas. 95.7.3597
70. Yoshimura, N., Suzuki, T., Hosoi, T., and Orimo, H. (2005). Epidemiology of hip fracture in Japan: incidence and risk factors. J. Bone Miner. Res. 23(Suppl.), 78-80. doi:10.1007/BF03026328
71. Zhou, R., Deng, J., Zhang, M., Zhou, H.-D., and Wang, Y.-J. (2011). Association between bone mineral density and the risk of Alzheimer's disease. J. Alzheimers Dis. 24, 101-108. doi:10.3233/JAD-2010-101467